Full-Life Technologies Announces U.S. FDA IND Clearance and Australian Regulatory Clearance for [²²⁵Ac]Ac-FL-261 Phase 1 Clinical Trial LONDON, Sept. 9, 2026 /PRNewswire/ — Full-Life Technologies ("Full-Life", the "Company"), a… CISION PRNewswireSeptember 9, 2026
SuperX Announces an Update on the Progress of Share Repurchases Program, to Demonstrate Confidence in Long-Term Growth Value SINGAPORE, Sept. 9, 2026 /PRNewswire/ — SuperX AI Technology Limited (NASDAQ: SUPX) ("SuperX"… CISION PRNewswireSeptember 9, 2026
Press ReleaseHyper3D Launches WorldGen to Turn Single Images into Editable 3D Scenes The Hyper3D world-generation model expands AI 3D generation from individual objects to… CISION PRNewswireSeptember 9, 2026
Press ReleaseSceye's Stratospheric Platform Re-enters United States After Record-Breaking Roundtrip Stratospheric Flight Between U.S. and Japan The journey, which lasted 30 days and traversed nearly 30,000 km, included… CISION PRNewswireSeptember 9, 2026
HR Path Strengthens SAP SuccessFactors Expertise as tts digital HR experts Joins the Group HR Path, a global leader in Human Resources, announces the acquisition of… CISION PRNewswireSeptember 9, 2026
Press ReleaseDJI Hosts Filmmakers & Visionaries Session at Venice Production Bridge During the 83rd Venice International Film Festival New Generation, New Cinematic Language: Osmo Pocket 4P Sparks a New Conversation… CISION PRNewswireSeptember 9, 2026
Press ReleaseBEYOND THE CANVAS: JEFF KOONS REIMAGINES TIME WITH HUBLOT NYON, Switzerland, Sept. 9, 2026 /PRNewswire/ — Hublot proudly announces an extraordinary… CISION PRNewswireSeptember 9, 2026
Transcenta Therapeutics and WuXi Biologics Enter into Strategic Collaboration to Accelerate Commercialization of HiCB Continuous Bioprocessing Technologies PRINCETON, N.J. and SUZHOU, China, Sept. 9, 2026 /PRNewswire/ — Transcenta Therapeutics (HKEX:… CISION PRNewswireSeptember 9, 2026
